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 
Abstract—Mock circulation loops (MCLs) are used to 
evaluate cardiovascular devices prior to in-vivo trials; however 
they lack the vital autoregulatory responses that occur in 
humans. This study aimed to develop and implement a left and 
right ventricular Frank-Starling response in a MCL. A 
proportional controller based on ventricular end diastolic 
volume was used to control the driving pressure of the MCL’s 
pneumatically operated ventricles. Ventricular pressure-
volume loops and end systolic pressure-volume relationships 
were produced for a variety of healthy and pathological 
conditions and compared with human data to validate the 
simulated Frank-Starling response. The non-linear Frank-
Starling response produced in this study successfully altered 
left and right ventricular contractility with changing preload 
and was validated with previously reported data. This 
improvement to an already detailed MCL has resulted in a test 
rig capable of further refining cardiovascular devices and 
reducing the number of in-vivo trials. 
I. INTRODUCTION 
OCK circulation loops (MCLs) are mechanical 
representations of the heart and circulatory system and 
are essential for in-vitro evaluation of cardiovascular devices 
prior to in-vivo trials [1]. These test rigs range from basic 
designs consisting of a preload chamber and resistance valve 
[2] to complex arrangements including multiple compliance 
chambers, variable resistance and functioning ventricles [3, 
4]. MCLs are usually designed specifically for evaluation of 
one cardiovascular device, such as a ventricular assist device 
(VAD) or heart valve [5, 6]. However, some systems have 
been developed with improved functionality and can be used 
to evaluate a wide range of devices [7, 8]. 
 Rosenberg et al. [7] reported on the development of the 
Pennsylvania State University MCL which  included both 
systemic and pulmonary circulations, arterial and venous 
compliance chambers, variable vascular resistance, and 
functioning ventricles. The MCL incorporates accurate 
representations of inertial, resistive and elastic properties of 
the heart and circulatory system under a range of simulated 
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conditions. However like many MCLs, an active ventricular 
Frank-Starling response (also referred to as Starling 
response) does not exist. The Starling response is a native 
autoregulatory mechanism that results in an increased 
ejection volume with increasing ventricular filling by 
increasing the force of ventricular contraction. Therefore, 
evaluation of cardiovascular devices is limited in MCLs 
without a Starling response as ventricular pressures, and 
hence cardiac output, incorrectly remain constant for 
changing ventricular volume.  
Previous attempts to implement a Starling response in a 
MCL have been made. Baloa et al. [9] implemented an 
elastance based control scheme which calculated the desired 
ventricular pressure based on instantaneous ventricular 
volume with a bellows pump ventricle. A separate control 
loop was then required to regulate the ventricular pressure 
based on the output of the elastance control loop. While 
demonstrating changing ventricular pressure with changed 
ventricular volume, the end systolic pressure volume 
relationship (ESPVR), usually non-linear in humans [10], 
was linear. Meanwhile, no right ventricular Starling response 
was simulated. Loh et al. [11] developed, in simulation, a 
MCL Starling response based on the work completed by 
Baloa et al., but with the addition of right atrial compliance 
and pressure dependent flow. Again, this simulation 
included no right ventricular Starling response, and only a 
limited range of preload was evaluated.  
A Starling response was implemented in a systemic only 
MCL with pneumatically operated ventricles by Pantalos et 
al. [12]. Little detail of the Starling implementation was 
given, however results were shown for varying Starling 
sensitivity. For all degrees of Starling sensitivity, the 
ESPVR appeared as though it would cross the x-axis at 
negative ventricular volumes. The x-intercept should occur 
at positive ventricular volumes as ventricular contraction 
will cease while a small residual volume remains [13]. A 
positive x-intercept was obtained by Ferrari et al. [14], who 
incorporated both left and right ventricular Starling 
responses in a MCL. This system controlled ventricular 
pressure based on ventricular volume with piston-cylinder 
type ventricles. While variable Starling response sensitivity 
was demonstrated with varying preload and afterload, the 
ESPVR was linear rather than concave towards the volume 
axis.  
The aim of this study was to develop and implement a 
variable non-linear biventricular Starling response in a MCL 
with pneumatically operated ventricles. This system can then 
be employed to evaluate cardiovascular devices more 
accurately under a wide range of pathological conditions. 
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II. METHODS 
A. Mock Circulation Loop 
A detailed MCL, based on a five element Windkessel 
model and consisting of systemic and pulmonary 
circulations, was used for Starling response simulation [1].  
Ventricular and atrial systole were controlled through a 
series of regulators (ITV2030-012BS5, IR3000-04, AR40-
04H-1 SMC Pneumatics, Brisbane, AUS) and 3/2 way 
solenoid valves (VT325-035DLS, SMC Pneumatics, 
Brisbane, AUS) to provide passively filled heart chambers 
and variable contractility, heart rate and systolic percentage 
(Figure 1). Ventricular pressure waveforms were smoothed 
by adjusting the electropneumatic regulator current supply at 
a frequency of 20Hz with a look-up table. Mechanical check 
valves were used to simulate the mitral, aortic, tricuspid and 
pulmonary valves to ensure unidirectional flow throughout 
the circuit. Windkessel chambers were employed to simulate 
lumped systemic and pulmonary arterial and venous 
compliance.  Proportional control valves (EPV-375B, HASS 
Manufacturing, NY, U.S.A.) allowed easy manipulation of 
systemic and pulmonary vascular resistance for efficient 
transition between healthy and pathologic conditions. 
Cardiovascular device evaluation was incorporated through 
various access points throughout the circuit.  
B. Starling Response Control 
A Starling response was simulated in the MCL’s 
pneumatic left and right ventricles through a proportional 
controller based on the real-time measurement of ventricular 
end diastolic volume (EDV). A schematic of the controller is 
shown in Figure 2.  A natural logarithmic function of EDV 
was used to scale the electrical current signal sent to the 
regulators. The natural logarithmic function was interpolated 
from the ESPVR described by Guyton (2005) [15]. The 
sensitivity of the MCL’s Starling response (and hence level 
of native ventricular function) was controlled by passing the 
output of the logarithmic function through a gain block.  The 
gain block was used to proportionally scale the output of the 
ventricular pressure shaping lookup table, resulting in a time 
varying electropneumatic regulator current signal that was 
dependent on preload. To ensure suitably low systolic 
pressures at low ventricular volumes, an offset constant was 
added to the EDV. The value of offset varied with heart 
function and was chosen manually. 
C. Starling Response Validation 
MCL parameters were manipulated to simulate a healthy, 
resting condition without a Starling response. The Starling 
response was then initiated and the sensitivity gain and EDV 
offset were manually adjusted through trial and error to 
produce an appropriate degree of contractility with a set 
ventricular preload. The shape of the ESPVR was then 
evaluated by decreasing MCL volume until ventricular 
volumes approached zero. A valve attached to the systemic 
venous chamber (SVC) was then partially opened to slowly 
redistribute fluid throughout the system to observe the 
response to increasing preload. MCL volume was then 
adjusted to achieve simultaneous left and right atrial 
pressures of 5, 10 and 15mmHg to observe the entire system 
response at various levels of preload. Both experiments were 
repeated for simulated conditions of mild and severe 
biventricular heart failure (BHF). 
D. Data Acquisition 
Haemodynamic parameters were captured at 100Hz using 
a dSPACE acquisition system (DS1103, dSPACE, MI, 
USA). Systemic and pulmonary flow rates were recorded 
using magnetic flow meters (IFC010, KROHNE, Sweden). 
Circulatory pressures were recorded using silicon-based 
transducers (PX181B-015C5V, Omega Engineering, 
Connecticut, USA). Ventricular volume was recorded using 
a magnetostrictive level sensor (IK1A, GEFRAN, Italy) 
which, when combined with the left ventricular pressure 
trace, produced pressure-volume (PV) loops. Post processing 
of the PV loops enabled capture of left ventricular ejection 
fraction and stroke work.   
 
Fig. 1.Ventricle chamber schematic. AC = compressed air source, 
HPMR = high pressure manual regulator, EPR = electropneumatic 
regulator, LPMR = low pressure manual regulator, SV = solenoid 
valve, MLS = magnetostrictive level sensor, LM = level magnet, VPS 
= ventricular pressure sensor, IV = inflow valve, OV = outflow valve 
 
Fig. 2. Schematic of the MCL’s Starling control and ventricular pressure 
shaping. EDV = end diastolic volume, ln = natural log function. 
 
 
 
III. RESULTS 
PV loops for the left and right ventricles with varying 
preload were created to evaluate the MCL’s simulated 
Starling response (Figure 3). As ventricular preload was 
increased, the end diastolic volume of each ventricle 
increased. This caused the MCL Starling control to increase 
the current supply to the electropneumatic regulators and 
hence increase the contractility of the ventricles. Figure 4 
shows the left and right ventricular ESPVR for conditions of 
healthy, mild and severe heart failure. This result 
demonstrates the increased gradient of the ESPVR with 
increased heart function. At low volumes, the gradient of the 
ESPVR was 1.82, 1.18 and 0.38mmHg/mL for healthy, mild 
BHF and severe BHF respectively. The concave relation to 
the x-axis reduced these gradients to 0.43, 0.41 and 
0.21mmHg/mL respectively for healthy, mild BHF and 
severe BHF. The right ventricular ESPVR gradient was also 
higher at low volumes, with values of 0.69, 0.23 and 0.1 for 
healthy, mild BHF and severe BHF respectively. For high 
volumes, the gradient for each condition had decreased to 
0.1mmHg/mL. 
The MCL’s Starling response is further characterized in 
Table 1, which summarizes the resultant haemodynamics for 
three levels of preload in simulated conditions of healthy, 
mild BHF and severe BHF. With an increase in left atrial 
pressure (LAP) from 5 to 15mmHg the systolic left 
ventricular pressure increased by 110mmHg in the healthy 
condition. This was reduced to 69mmHg in mild BHF, with 
severe BHF demonstrating a further reduction in ventricular 
contractility with only a 34mmHg difference with the same 
change in LAP. Mean systemic flow rate followed similar 
trends, with a 2.6L/min change in the healthy condition 
compared to only 1.0L/min in severe BHF with an LAP 
increase from 5 to 15mmHg. Although not as severe, similar 
trends were noted with the pulmonary haemodynamics. With 
a change in right atrial pressure from 5 to 15mmHg, the 
systolic right ventricular pressure increased 22mmHg in the 
healthy condition compared to only 13mmHg in the severe 
BHF case.  
IV. DISCUSSION 
Addition of an accurate Starling response in a MCL 
increases the system’s ability to simulate the native heart’s 
function and allows for more reliable evaluation and 
refinement of cardiovascular devices. Attempts to simulate a 
MCL Starling response have been made previously, however 
these systems generally only include the left heart and use 
linear ESPVRs which cross the x-axis at negative values [9, 
11, 12, 14]. Although not shown at low volumes, the 
i)   ii)   
Fig. 4. End systolic pressure-volume relation (ESPVR) for conditions of healthy, mild heart failure and severe heart failure in the i) left and ii) 
right ventricles. MLHF = mild left heart failure, SLHF = severe left heart failure, MRHF = mild right heart failure, SRHF = severe right heart 
failure, LVPsys = systolic left ventricular pressure, LVVsys = end systolic left ventricular volume, RVPsys = systolic right ventricular pressure, 
RVVsys = end systolic right ventricular volume. 
0 50 100 150 200
0
50
100
150
200
LVVsys (mL)
LV
P
sy
s 
(m
m
H
g)
 
 
Healthy
MLHF
SLHF
0 50 100 150 200
0
10
20
30
40
50
RVVsys (mL)
R
V
P
sy
s 
(m
m
H
g)
 
 Healthy
MRHF
SRHF
i)               ii)  
Fig. 3. Pressure-volume (PV) loops for i) left and ii) right ventricles in a healthy, resting simulation with gradually increasing preload. LVP = left 
ventricular pressure, LVvol = left ventricular volume, RVP = right ventricular pressure, RVvol = right ventricular volume. 
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ESPVRs generated in our study appear to cross the x-axis at 
positive values for all conditions in both the left and right 
ventricles. While often linear in smaller animals, the ESPVR 
is usually concave to the x-axis in humans [10]. The Starling 
response in our study achieved the concave shape through 
multiplication of EDV with a natural log function.  
The ESPVR gradient matched closely with previously 
reported data for the left ventricle in healthy (0.6-
2.22mmHg/mL) and heart failure conditions 
(0.28mmHg/mL) [9, 12, 14]. Brown et al. [16] reported 
values for a healthy human right ventricular ESPVR gradient 
vary between 0.32 and 1.23mmHg/mL at low right 
ventricular volumes, which also fits with our results. 
However, no data for the right ventricular ESPVR gradient 
at high volumes could be found. The ability to easily vary 
the Starling sensitivity in our controller enables simulation 
of almost any Starling response and is only limited by the 
minimum output capacity of the electropneumatic regulators. 
However, it should be noted that our controller only altered 
the Starling sensitivity and not the preload sensitivity of the 
ventricles, which would also include changes in heart rate.  
The addition of a Starling response in the right ventricle 
for a pneumatically operated ventricle has not been reported 
previously. Throughout the validation process, the 
importance of a right ventricular Starling response was 
obvious, as it was this response which ultimately determined 
left ventricular preload. This demonstrates a noticeable 
limitation of systemic only Starling responsive MCLs, as 
they lack independent ventricular preload variability. 
Meanwhile, our study would also benefit from the addition 
of a controllable and non-linear end diastolic pressure 
volume relationship (EDPVR), which varies in humans and 
influences the filling capacity of the ventricles [10].  
V. CONCLUSION 
MCLs are a valuable tool for evaluation of cardiovascular 
devices, however, current MCLs lack accurate 
autoregulatory responses observed in-vivo. Implementation 
of the Starling response was achieved in a MCL with a 
proportional controller which adjusted pneumatic ventricular 
driving pressure based on ventricular end diastolic volume. 
The Starling response was implemented in both ventricles 
and successfully demonstrated increased ventricular 
contractility with increased preload. ESPVR curves were 
generated and validated against previously reported human 
data to ensure the system response was a suitable human 
model under various healthy and pathological conditions. 
This improvement to a MCL will enable more accurate 
evaluation and further improvement of cardiovascular 
devices to treat end stage heart failure patients. 
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TABLE I 
HAEMODYNAMICS FOR SIMULTANEOUS ADJUSTMENT OF LEFT AND RIGHT VENTRICULAR PRELOAD IN HEALTHY, MILD BIVENTRICULAR HEART FAILURE AND 
SEVERE BIVENTRICULAR HEART FAILURE 
Condition LAP (mmHg) 
LVPsys 
(mmHg) 
MAP 
(mmHg) 
MSQ 
(L/min) 
RAP 
(mmHg) 
RVPsys 
(mmHg) 
MPAP 
(mmHg) 
MPQ 
(L/min) 
Healthy 5 73 52 3.4 5 21 9.3 3.4 
 10 141 110 5.2 10 33 20 5.2 
 15 183 146 6.0 15 43 28 6.0 
Mild BHF 5 59 39 2.8 5 19 8 2.8 
 10 102 78 4.1 10 27 15 4.1 
 15 128 99 4.7 15 34 20 4.7 
Severe BHF 5 48 29 2.3 5 15 5 2.3 
 10 68 48 3 10 23 10 3 
 15 82 60 3.3 15 28 14 3.3 
LAP = left atrial pressure, LVPsys = systolic left ventricular pressure, MAP = mean aortic pressure, MSQ = mean systemic flow rate, RAP = right atrial 
pressure, RVPsys = systolic right ventricular pressure, MPAP = mean pulmonary arterial pressure, MPQ = mean pulmonary flow rate. 
